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GLAUCOMA: PAST AND PRESENT
MANAGEMENTTECHNIQUES
David M. Tinsley, D.V.M.*
Daniel M. Betts, D.V.M., MSc., Dip.ACVO.**
Abstract
This article reviews the clinical signs and
diagnostic modalities appropriate for glaucoma.
Classification of this disease and currently
recommended treatment options are discussed.
Introduction
Glaucoma is a group of eye diseases
characterized by an increase in intraocular
pressure which causes pathological changes in
the optic disc and typical defects in the field of
vision. 1 Generally accepted normal intraocular
pressure (lOP) readings in the dog and cat
range from 15-30 mmHg. Maintenance of
normal pressure is through a delicate balance of
aqueous production and outflow. The formation
of aqueous 11umor is dependent on three
dynamic processes. Active transport is the most
important of the three and results in the move-
ment of Na+ ions from the blood into the
aqueous humor against a concentration gradient
through the use of energy dependent Na+/K+
ATPase pumps located in the non-pigmented
epithelial cells overlying the ciliary body pro-
cesses.2. Carbonic anhydrase catalyzes the
reaction: CO2 + H20 <-> H2C03 + HC03- <->H+.
Entry of bicarbonate is associated with influx of
water into the posterior chamber. The remain-
der is a cornbination of solute movement down a
concentration gradient (passive diffusion), as
well as movement across cell mefl1branes
secondary to local hydrostatic forces (ultrafiltra-
tion). Resultant aqueous humor collects in the
posterior chamber of the globe. It then flows
through the pupillary apel1ure, anterior chamber,
pectinate ligaments, trabecular meshwork of the
ciliary cleft, scleral venous plexus to be trans-
ported via the local efferent vascular channels
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away from the globe. This conventional
"corneoscleral" route accounts for 85-900/0 of the
total aqueous outflow.2 The remaining 10-15%
exits via the unconventional "uveoscleral"
outflow diffusing posteriorly through the iris,
ciliary body, and choroid into the suprachoroidal
space and adjacent sclera.2. In order to have an
increased lOP, there must be either an in-
creased production or decreased outflow.
Increased production (hyperfiltration) has never
been documented, hence, all glaucomas are
based on impaired circulation or outflow.
Diagnosis-Clinical Signs
Early recognition of glaucoma is mandatory if
successful regulation of intraocular pressure
with subsequent preservation of vision is to be
achieved. Establishing a diagnosis of glaucoma
is based exclusively on measurement of the
intraocular pressure. If such diagnostics are to
be performed, the clinician must first have a
reasonable index of suspicion that the disease
is in fact present. As a rule, the presenting
history is unlikely to be of much value. With this
in mind, initial physical examination findings are
often the first reliable tool available to the
clinician in establishing the diagnosis. Unfortu-
nately, those clinical signs that are consistently
expressed in acute glaucoma mimic those of the
more commonly presented extraocular red eye
disorders. These include lacrimation,
photophobia, blepharospasm and variable
congestion of the conjunctival/episcleral vessels
secondary to shunting of aqueous/venous
outflow (Fig. 1). Where lOP exceeds 40 - 45
mmHg, corneal stromal edema develops
secondary to impaired dehydration by the
endothelial based Na+/K+ ATPase pump.
Mydriasis is an important clinical finding which
can aid in differentiating glaucoma 'from uveitis.
This loss of tone to the constrictor pupillae is a
sequelae to extinguished retinal stimulation and
direct pressure effects on the iris stroma (Fig. 2).
Blindness results from retinal ischemia as
elevated lOP prevents normal hemodynamic
flow to this tissue. Therapy instituted to
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normalize lOP may reoxygenate retinal photore-
ceptors in time to restore vision. Digital palpa-
tion of the globe may reveal a "hard eye". This
technique is inconsistently reliable in cases of
moderate pressure elevations.
As the disease progresses, signs that were
initially variable (Table 1) become reliably
present. With chronicity, elevated lOP results in
enlargement of the globe (buphthalmos),
thinning of the equatorial sclera with uveal
herniation (equatorial staphyloma) and rupture
of Descemet's membrane. Ensuing full thick-
ness corneal edema is seen clinically as linear
white fissure in the stroma (Fig. 3).
Malpositioning of the lens is either the cause of
the glaucoma (ie. anterior luxation) or a
sequelae to buphthalmos induced zonular
rupture (most subluxations). Cataract formation
and liquefaction of the vitreous (syneresis) are
fiequently seen associated with altered aqueous
dynamics. Ophthalmoscopic examination yields
two commonly observed abnormalities. Cup-
ping of the optic nerve head is seen clinically as
truncated retinal vessels at the optic nerve head
which is not in the same plane of focus as the
remainder of the fundus (Fig. 4).Posterior
mechanical displacement of the lamina cribrosa
with subsequent distortion of the laminar pores
prevents the normal axoplasmic and hemody-
namic flow necessary for retinal viability.
Accompanying retinal degeneration is seen as
tapetal hyperreflectivity, retinal vascular
attenuation, and hyperpigmentation of the
tapetal fundus as pigment infiltrates from the
adjacent retinal pigment epithelium (Fig. 4).
Eventually the diagnosis is obvious, but not until
vision has been irreversibly lost (Table 2).
Table 1
Clinical Signs of Acute Glaucoma
1. Lacrimation
2. Photophobia
3. Blepharospasm
4. Congestion of conjunctival/episcleral
vessels
5. Corneal edema
6. Mydriasis
7. Blindness
8. "Hard" eyes
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Table 2
Clinical Signs of Chronic Glaucoma
1. Continued engorgement of conjunctival
episcleral vasculature
2. Buphthalmos
3. Blindness
4. Corneal edema
5. Striate keratopathy
6. Equatorial staphyloma
7. Mydriasis
8. Lens luxation/subluxation
9. Cataracts
10. Liquefaction of the vitreous (syneresis)
11. Optic nerve cupping
12. Tapetal hyperreflectivity
Diagnosis - Tonometry
Establishing a definitive diagnosis can only
be through the measurement of the lOP. The
most routinely employed method of estimating
lOP in veterinary practice is digital tonometry.
Although this method elirrlinates the need to
purchase additional instrumentation, it is entirely
too insensitive to assess those subtle pressure
alterations occurring in early glaucoma sus-
pects. As such, digital tonometry cannot be
recommended for the recognition or manage-
ment of glaucomatous eyes where retention of
vision is the main objective.
Instrumentation tonometry is generally
divided into two distinct groups, indentation or
applanation tonometry. Both have thei r
advantages and disadvantages. The Schiotz®
indentation tonometer is the most widely
purchased tonometer for veterinary practice.
This instrument measures the amount of corneal
indentation achieved with the addition of a
given, yet variable, amount of weight. Although
very cost effective and accurate, this instrument
does posses a relatively large foot plate, thereby
making it more susceptible to the influences of
"scleral rigidity" or concurrent corneal pathology.
One other drawback, especially when used in
large animal practice, is that it must be used in a
vertical orientation. Alternatively, applanation
tonometers have the advantages of a relatively
small foot plate and can be used in any orienta-
tion. Compared to indentation units, these
instruments determine the amount of pressure
required to flatten or "applanate" the given area
of cornea below their foot plate. Although
numerous models are currently marketed, they
are considerably more expensive than the
Schiotz® tonometer, and usually are available
only at referral centers.
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Diagnosis - Classification
Once an elevation in lOP has been deter-
mined, classification of the glaucoma is essential
if the correct therapeutic approach is to be
undertaken. Numerous classification schemes
have been described to date. One of the most
widely accepted systems differentiates glauco-
mas into one of three headings. Primary
glaucomas are those cases where there is no
antecedent intraocular disease. When glaucoma
is thought to be the result of pre-existing
intraocular disease it is termed secondary
glaucoma. Commonly observed causes of
secondary glaucoma include anterior uveitis,
hyphema, intraocular neoplasia, lens luxation,
peripheral anterior synechiae, and 3600 posterior
synechiae \AJith resultant iris bombe. Establish-
ing the inciting cause for glaucoma maximizes
the chance for successful pressure control as
standard medical therapy of primary glaucoma
is routinely unsuccessful in these individuals.
Although the management of secondary
glaucoma is beyond the scope of this article,
those glaucomas which are secondary to uveitis
are best managed by aggressive
antiinflammatory therapy, while those resulting
from lens luxation must ultimately be corrected
with intracapsular lens extraction. In the dog
and cat, secondary glaucoma is more common
encountered than primary glaucoma.
Veterinary ophthalmologists believe primary
glaucoma in the dog is an inherited disorder.3 At
present, the mode of inheritance is unknown.
Primary glaucomas are subdivided into three
subsets based on gonioscopic evaluation.
These include open angle glaucoma, narrow/
closed angle glaucoma and goniodysgenesis.
As most veterinary practitioners are not
equipped with goniolenses or gonioprisms,
evaluation of the drainage angle is first per-
formed by the veterinary ophthalmologist. A
simple method of performing gonioscopy using
a +200 to +300 hand held lens has recently
been described.4 After application of a topical
anaesthetic to the cornea, the lids are retracted
and the flat side of the condensing lens is gently
pressed against the axial cornea such that the
precorneal tear film wets the lens surface.
Focusing is achieved by the exanliner moving
closer or further from the patient.4 Although
differentiating between these three subgroups is
unlikely to alter the initial therapeutic approach,
it is still of paramount importance to the patient.
Since the typical glaucoma referral patient has
already lost vision in one eye, gonioscopic
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evaluation of the fellow eye helps to establish
whether it is also at risk. Early surgical interven-
tion in the fellow eye appears to significantly
prolong normal lOP with subsequent retention of
vision for these patients. In man the vast
majority of primary glaucoma patients are of the
open angle type. Among dogs only the beagle,
toy and miniature poodle have been shown to
fall into this category.2 Narrow angle glaucoma
is the most common form of primary glaucoma
identified in the dog (Table 3). The remainder
have an incompletely developed drainage angle
and are classi'fied as goniodsygenesis. Breeds
typically exhibiting these findings include Basset
Hounds, Bouvier des Flandres, Chihuahua,
Giant Schnauzer, American Cocker Spaniel,
C,..rY\",,,,,,rI ,."nrl ~r'\"'\",,"\+h nnn ,,,,iro ~f'\V Torriorc 2 It
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is important to realize that although individuals
of these breeds often have gonioscopically-
apparent angle abnormalities, they may also
have enough unaffected angle to permit normal
outflow thereby avoiding clinically evident
elevations in lOP. Basset hounds and American
Cocker Spaniels are the two breeds most likely
to develop clinical disease.
Table 3
Narrow Angle Glaucoma
Akita
American cocker spaniel
Basset hound
Beagle
Chihuahua
Dachshund
English cocker spaniel
English springer spaniel
Maltese
Miniature and Toy poodle
Norwegian elkhound
Siberian husky
Smooth and Wire fox terriers
Welsh springer spaniels
Treatment
There is little doubt that control of lOP in
primary glaucoma patients is one of the most
frustrating aspects of veterinary ophthalmology.
Although there have been a wide variety of
techniques proposed by a plethora of authors,
the traditional approach has been to control lOP
through medical management for as long as
possible, and to treat surgically only when
medical control was lost and vision was
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compromised. 5 A large part of this rational was
based on the poor long-term success of the
available surgical options at that time. With the
recent advent of significantly improved surgical
devices, the approach to the glaucomatous
individual that still displays the potential for
salvageable vision, has changed.
Our present day protocols for the glaucoma
suspect is to first determine the potential for
salvaging vision. For those individuals with a
realistic chance of vision retention, initial
medical management is indicated. Once
pressures have been normalized, surgical
intervention is generally performed. In those
cases where there is no hope for vision, surgical
intervention at the surgeons convenience is
indicated, with administration of systemic
analgesic medication during the interim.
~v1edicalManagernent
Therapeutics used in glaucoma management
fall into one of 'five classes (Table 4). When
there is a significant elevation in lOP the most
efficacious class of drugs is the osmotic
diuretics. These drugs function, not through
their ability to induce diuresis, but rather through
the generation of a hypertonic serum. As serum
osmolality increases, fluid is drawn into the
vascular compartment from the intracellular and
extracellular fluid spaces. In the presence of an
intact blood-eye barrier, fluid is selectively drawn
from the vitreous and aqueous humor into the
periocular vasculature. In eyes with concurrent
uveitis, the overall efficacy of osmotic diuretics
often is significantly reduced. The clinician must
be cautious when these drugs are used in the
presence of cardiovascular insufficiency as the
resultant vascular hypertension could further
compromise these patients.
The second class of drugs is the carbonic
anhydrase inhibitors (CAl). These drugs reduce
the active transport component of aqueous
humor production by interfering with the
carbonic anhydrase enzyme at the level of the
nonpigmented ciliary body epithelium. Although
reducing the rate of aqueous formation in
individuals who suffer from a decreased
coefficient of outflow seems unphysiologic, the
net effect is often favourable. It should be noted
that the active transport component of aqueous
humor production often is reduced in the
presence of significant intraocular inflammation
or elevated lOP. Therefore, using these drugs
as the primary therapeutic regimen in the
management of high tension glaucomas or
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glaucomas secondary to intraocular inflamma-
tion is unlikely to be effective and cannot be
recommended. Their main role appears to be in
the short term management of low tension
glaucomas, as chronic usage often results in
systemic metabolic acidosis.
A variety of topical direct and indirect acting
parasympathomimetic drugs also have been
advocated in the regulation of elevated lOP. In
man it has been demonstrated that contraction
of the longitudinal ciliary body muscle results in
increased tension on the scleral spur and
subsequent opening of the drainage angle.
Although a scleral spur has yet to be identified in
domestic animals, the use of these drugs have
been extrapolated to these species. In individu-
als with a narrow angle glaucoma it is postu-
lated that with a pupillary dilation the base of the
iris becomes thickened and loose, resulting in
an increased tendency to crowd the already
compromised drainage angle. Stimulation of the
constrictor pupillae muscle draws the base of
the iris axially thereby opening the angle and
improving outflow. These smooth muscle
stimulatory effects in combination with occa-
sional contact sensitivity are responsible for the
variable signs of ocular irritation seen in some
patients receiving these medications.
Use of drugs within the following two
categories are also direct extrapolations from
human glaucoma therapy. In general, these
products have failed to show consistently
reproducible clinical success in the manage-
ment of our veterinary glaucoma patients.
Possible reasons for these disappointing results
may lie in the fact that although the vast majority
of primary glaucoma in the dog are narrow
angle glaucomas, in man primary open angle
glaucomas are the routine. As such it may be
unreasonable to expect significant clinical
improvement in our patients while on these
medications.
Direct acting sympathomimetic drugs appear
to act primarily through their beta effects.
Stimulation of beta receptors results in in-
creased cAMP activity in the region of the
drainage angle resulting in increased outflow
facility and decreased lOP. Conversely,
topically applied beta blockers appear to
decrease cAMP activity in the region of the
ciliary body processes resulting in decreased
aqueous formation and reduced lOP. Interest-
ingly, in man, combining an agonist (epineph-
rine) and an antagonist (timolol/betaxolol) have
an additive effect to decrease lOP.6 Although
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clinical trials in domestic animals suggest that
such protocols are often unsuccessful in
regulating the problem, research on human
patients has shown that these results are likely
obtained through an "anatomic separation of
activity"; i.e. epinephrine affecting the outflow
pathways I timolol and betaxolol influencing the
ciliary processes6 •
Table 4
Medical Management of Glaucoma
1. Osmotic diuretics
(i) mannitol (IV) @0.5-1 gml lb. orally
over 20-30 ITlin.
(ii) glycerol (oral) @ 0.3-0.5 mil lb.
2. Carbonic anhydrase inhibitors
(i) dichiorphenamide (DaJanide+) @
1- 2 mgl lb. PO BID
(ii) methazolamide (Neptazane+) @
2-4 mgl lb. PO BID
(iii) acetazolamide (Diamox+) @ 5
mgl lb. PO BID
3. Miotics
(i) pilocarpine @ 0.5/1 .012.0 0/0
topical sol's.
(ii) echothiophate (Phospholine
iodide+) @ 0.06-0.25 % 1 gtt. bid
(iii) demecarium bromide (Humorsol+)
@ 0.125/0.25 % 1 gt1. bid
4. Adrenergic (sympathomimetics) drugs
(i) epinephrine - 1 gt1. bid
(ii) dipyvalyl epinephrine (Propine+)
1 gt1. bid
5. Beta - blockers
(i) timolol (Timoptic+)- non selective
B1 + B2 antagonist; 1 gt1. bid
(ii) betaxolol (Betoptic+)- selective
B1 antagonist; 1 gt1. bid
Surgical Management - Visual Eyes
Veterinary ophthalmologists generally agree
that long term control of glaucoma patients in
veterinary medicine has been extremely
unrewarding. One of the initial surgical attempts
was with the application of heat to the ciliary
body by 'first passing an electrode through the
overlying sclera. This process of cyclodiathermy
was soon abandoned due the cOlTlplications of
postoperative inflammation and fistulation.7
Cyclocryosurgery was attelTlpted, first with a
nitrous oxide8-10 sources and later using liquid
nitrogen.8 ,9,11,12 In this procedure a cryoprobe is
placed on the bulbar conjunctiva approximately
5 mm caudal to the limbus and an ice ball is
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created w~lich extends deep enough to involve
the underlying ciliary body and epithelium. The
goal of this procedure is not to produce massive
necrosis of tissue, but rather to cause focal areas
of atrophy and fibrosis of the ciliary body and
covering epithelium with resultant decrease in
aqueous humor production. 11 ,12 The initial effects
are a related to tissue dehydration. This results
in increased electrolyte concentration and cell
membrane lipoprotein denaturation as extracellu-
lar and intracellular water crystallization occur. 11
A fast freeze is preferred. Slow "freezes result in
a progressive depression of the cytoplasmic
freezing point as the extracellular ice crystals pull
free water from the cells. Thus, intracellular ice
crystallization is less likely to occur and lethal
changes in the cell may be delayed. 11 This
problem can be minimized using a fast freeze
cycle as this results in both intracellular and
extracellular ice crystal formation. With this in
mind the trend has been away from nitrous oxide
units and towards liquid nitrogen systems.
Typically a 2.5 mm or 4 mm probe is applied to
the globe 4-6 times approximately 5 mm caudal
to the limbus.8,1o,11 As a result of ciliary body
temperatures achieved in experimental studies, it
has been recommended that the probe remain
activated until the resultant ice ball extends into
the cornea 1 mm beyond the Iimbus.11 This
appears to provide reliable freezing to the
underlying ciliary body.
This procedure can be repeated if initial
results are not satisfactory. Chemosis,
conjunctivitis, corneal granulation tissue, iris
depigmentation, choroidal effusion with retinal
detachment, uveitis, transient elevations in
intraocular pressure7-9 , and phthisis bulbi10 all
have been described. As such, most patients
are treated postoperatively with oral carbonic
anhydrase inhibitors and systemic analgesics. It
is the opinion of certain authors8,9 that the high
prevalence of retinal detachments and postop-
erative intraocular elevations in lOP should
restrict the use of this procedure for non-visual
mildly buphthalmic globes. Here it routinely
provides relief 'from pain and a cosmetically
acceptable endpoint8,9. At present transscleral
cryosurgical destruction of the ciliary body
remains the most common surgical procedure
used to treat dogs with glaucoma.13 Conversely,
in man it has been recommended as a method of
treating a variety of causes of glaucoma includ-
ing open and closed angle glaucomas.12
More recently, cyclophotocoagulation has
been employed as an alternative method to
Iowa State University Veterinarian
reduce aqueous humor production in an effort to
regulate lOP in normotensive? and
glaucomatous individuals.13 In domestic a.nimals
the energy source being used is the neodymium
: yttrium, aluminum, and garnet (Nd : YAG)
laser. This instrument emits light in the near
infrared spectrum ( wavelength = 1,060 nm)
which is produced by the photic stimulation of
the neodymium atoms suspended in a crystal of
yttrium, aluminum, and garnet.? At the present
time, the uses of thermal Nd : YAG lasers in
veterinary ophthalmology include transpupillary
and transscleral cyclophotocoagulation and
iridotomy.13 Initial results of its use in both
normotensive and glaucomatous individuals
suggest a prornising future in the regulation of
lOP in the dog.?·13 Commonly encountered post
operative complications include focal conjunctival
hyperemia and edema, aqueous flare with
concurrent iritis, mild diffuse corneal edema and
variable ciliary hemorrhage and necrosis.? When
followed to 24 weeks, occasional cataract
formation was encountered.13 Of those
glaucomatous individuals which were not
controlled by this procedure, 75% had reduced
uveal pigmentation. This is not surprising as
thermal energy is preferentially absorbed by
pigmented tissues.? Comparison with
cyclocryosurgery suggests that this procedure is
associated with less pain, inflammation,
exudational retinal detachments and a shorter
period of postoperative intraocular hyperten-
sion.?·13 These encouraging findings must be
tempered by the apparent cataractogenic
potential along with the inherent cost and limited
availability of the instrumentation.
Filtration Procedures
Given that the problem is one of decreased
outflow rather than overproduction, a more
physiological approach would attempt to facilitate
aqueous outflow. Such filtration surgeries can
best be divided into one of two groups, those
with implants and those without. A wide variety
of non-implant procedures have been described
all of which involve creation of a new conduit for
aqueous outflow. These include iridencleisis,
cyclodialysis, peripheral iridectomy, combined
iridencleisis-cyclodialysis, corneoscleral trephina-
tion-peripheral iridectomy, cyclodialysis-
iridocyclectomy, and posterior sclerectomy-
cyclodialysis-transscleral iridencleisis.2,13-15
Based on the high degree of expertise required
of the surgeon, along with the tendency for early
failure secondary to scarring and 'fibrosis at the
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surgical site, these techniques are now largely
of historical interest.2 ,13
One of the new and evolving areas in canine
glaucoma research is the use of anterior
chamber implants. Currently there are a wide
variety of implant devices being used for
glaucoma management in both man and dog. All
incorporate a hollow silicon tube which 'function
as a sclerostomy opening to shunt aqueous to
the adjoining polypropylene or silicon foot plate
(scleral explant) (Fig. 5) Emergent aqueous
collects in the surrounding filtering bleb and is
ultimately taken up by the regional vascular
channels. 16 Following the development of
postoperative fibrosis at the 'filtration site, this
area acts as the main regulator of lOP. Surgica.l
implantation involves incising a variable length of
dorsal bulbar conjunctiva and dissecting
posteriorly to accommodate the scleral explant
The explant is then secured to the underlying
sclera and a tunneling dissection between the
conjunctiva and underlying sclera is extended
anteriorly towards the limbus. A few millimeters
caudal to the limbus is the site of globe penetra-
tion. This is often performed using a 20-22
gauge hypodermic needle after which the silicon
tube is trimmed to the appropriate length and
inserted into the anterior chamber. Finally, the
overlying wound is reapposed and the anterior
chamber reformed (Fig. 6). There is controversy
as to whether non-valved systems require
temporary ligation to prevent the immediate
postoperative hypotony seen in man. The exact
depth in the subconjunctival tissue that the
scleral explant should be in order to optimize the
duration of useful drainage also rema.ins to be
determined Although none have proven to be
superior under all conditions, studies with limited
numbers of patients suggest this is a signi'ficantly
improved method for control of canine glauco-
mas.5,16
Development of gonioimplants in the dog has
only recently been reexplored. First implanted in
canine patients in the late 1970's, the original
Krupin-Denver Valve was tested in both normo-
tensive and glaucomatous beagle dogs.1? The
initial success of these implants proved to be of
short duration. The primary problem with this
implant lay in the fact that the posterior end of
the sclerostomy tubing terrninated abruptly in the
anterior subconjunctival space without the benefit
of an adjoined scleral explant. This resulted in
premature scarring and drain occlusion.5 More
recently a modi'fication of the Joseph one-piece
drainage implant was used in 15 dogs (21
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eyes).18,19 Results obtained over a follow-up
period of nine months or more suggested
superior long term control over all other currently
used surgical techniques. 18 The principle
difference between this implant and the previ-
ously described Krupin-Denver Valve is the
addition of a large silicon rubber strap-like scleral
explant used to distribute the emergent aqueous
over a much greater surface area. Once the fluid
had accumulated in this filtration reservoir it was
subsequently absorbed and removed by the
surrounding efferent vasculature. As clinical
trials continued, it was determined that the valve
assembly in this device was unnecessary for the
canine as there was no evidence of significant
postoperative hypotony and anterior chamber
collapse as is routinely observed in man. It was
also the opinion of the author that the vaive may
interfere with drainage of the copious amounts of
surgically induced exudate often encountered in
the dog, reSUlting in early tube occlusion. 18 To
test this theory many of the implants had their
valve assemblies modified to be nonfunctional.
Overall success rates at nine months following
surgery approached 80% with approximately
50% still receiving additional hypotensive
medication.18 It should be noted that all individu-
als in this study18 were selected only after
medical therapy was found to be inappropriate or
ineffective. Furthermore, vision was also
maintained in eyes that received surgery prior to
clinically detectable damage to the optic
nerve.16,18
Surgical Managenlent - Nonvisual Eyes
The primary goal of therapy in non-visual
eyes is pain relief, while attempting to produce a
cosmetically acceptable result for the client.
Cyclocryosurgery is exceedingly useful in this
role and is routinely utilized by many veterinary
ophthalmologists for this purpose. An alternative
method used to permanently reduce aqueous
production is that of an intracameral injection of a
gentamicin/dexamethasone solution. Following
administration of the solution, the clinician is
unable to accurately estimate the final size of the
treated globe. Furthermore, safe and effective
introduction of this solution into the globe
requires initial aspiration of liquefied vitreous. If
not liquefied, the vitreous is difficult or impossible
to aspirate. A third option is the introduction of a
medical grade silicon ball following removal of
the entire contents of the globe (evisceration)
through a linear incision in the dorsal sclera.
Although this offers a certain predictability to the
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eventual size of the globe, based on the size of
the previously selected intraocular prosthesis, it
is not recommended in the presence of corneal
ulceration or degeneration. Where there is
concern of intraocular infection or neoplasia all
affected globes should be enucleated and sent to
a veterinary pathologist for histopathologic
evaluation.
Summary
Appropriate management of the glaucoma
suspect requires early recognition of the clinical
signs and prompt initiation of therapy. Accurate
diagnosis can only be established through the
use of a mechanical tonometer. Determining the
existence of antecedent intraocular disease
pen-nits selection of the most appropriate
therapy. Secondary glaucoma is more common
than primary glaucoma in the dog. Although the
exact mode of inheritance is undetermined, most
veterinary ophthalmologists believe primary
glaucomas to be inherited. Treatment of
secondary glaucoma is directed at the inciting
cause. Medical management of primary is only
recommended for immediate pressure stabiliza-
tion in eyes where vision is felt to be salvage-
able. Long-term management requires surgical
intervention. History shows the evolution of
numerous medical and surgical options used to
regulate lOP. Where such a diversity of tech-
niques exist, likely none excel. Perhaps the
initially favourable results achieved through the
use various gonioimplants will establish this as
the definitive method of regulating lOP, and more
importantly preservation of vision, in these
patients.
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Fig. 1 Clinal signs include lacrimation, photophobia, blepharospasm and
variable congestion of the conjunctival/episcleral vessels.
Fig. 2 Corneal stromal edema with resultant
3600 vascular invasion, mydriasis,
and continued engorgement of
the conjunctival/episcleral vessels.
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Fig. 3 Linear areas of full thickness corneal
edema superimposed on a diffusely
edematous stroma, persistence of
mydriasis, corneal vascularization and
congestion of the associated vessels.
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Fig. 4 Cupping of the optic nerve head, diffuse retinal degeneration with
accompanying tapetal hyperreflectivity, retinal vascular attenuation,
and mottled depigmentation of the RPE in the non-tapetal fundus.
Fig. 5 Baerveldt® gonioimplant
prior to implantation.
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Fig. 6 Baerveldt® implant immediately
postoperatively.
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